Therapeutic Delivery Specifications Identified Through Compartmental Analysis of a Mesenchymal Stromal Cell-Immune Reaction
Abstract Despite widespread preclinical success, mesenchymal stromal cell (MSC) therapy has not reached consistent pivotal clinical endpoints in primary indications of autoinflammatory diseases. Numerous studies aim to uncover specific mechanisms of action towards better control of therapy using in...
Guardado en:
Autores principales: | Matthew Li, Danika Khong, Ling-Yee Chin, Amy Singleton, Biju Parekkadan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/782a48001def412f8bfcf8ee08491cdc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacokinetics of natural and engineered secreted factors delivered by mesenchymal stromal cells.
por: Jessica S Elman, et al.
Publicado: (2014) -
Mesenchymal stromal cell apoptosis is required for their therapeutic function
por: Swee Heng Milon Pang, et al.
Publicado: (2021) -
Immune response to allogeneic equine mesenchymal stromal cells
por: J. Lacy Kamm, et al.
Publicado: (2021) -
Alginate encapsulation for bupivacaine delivery and mesenchymal stromal cell immunomodulatory cotherapy
por: Davis MS, et al.
Publicado: (2019) -
Mesenchymal Stromal Cell Secretome for the Treatment of Immune-Mediated Inflammatory Diseases: Latest Trends in Isolation, Content Optimization and Delivery Avenues
por: Elena Munoz-Perez, et al.
Publicado: (2021)